Follow your curiosity

What discovery has been shared with you?

Start with one fact. Explore it, go deeper, then follow whichever branch catches your imagination.

Choose subjects for a surprise

Exploring any topic

Begin your discovery

Your next discovery is one click away.

Choose one or more subjects above, or leave Any Topic selected and let curiosity decide.

Medicine

Epidemiology and control of carbapenem-resistant enterobacteriaceae in healthcare facilities

Quick fact

In some hospitals, up to 10% of Enterobacteriaceae isolates are carbapenem-resistant, and bloodstream infections with these bacteria have mortality rates exceeding 40%.

Why this is interesting

Imagine a hospital where common antibiotics fail. A type of bacteria, normally treatable, is now resistant to our last-line drugs. How does this happen, and how can we stop it?

Read the full explanation

Understanding Epidemiology and control of carbapenem-resistant enterobacteriaceae in healthcare facilities

Enterobacteriaceae are a family of bacteria that live naturally in the human gut. They include familiar species like E. coli and Klebsiella pneumoniae. Normally, they can cause infections, but they are usually treated with antibiotics called carbapenems. These drugs are powerful and are often the last line of defense. However, some bacteria have acquired genes that produce enzymes (like KPC or NDM) that break down carbapenems, making the bacteria resistant. This resistance is often carried on plasmids, small DNA pieces that can move between bacteria, spreading resistance rapidly. When a patient carries such bacteria (colonization) without infection, they can still shed the bacteria and contaminate their surroundings. Healthcare workers' hands and contaminated surfaces are key routes of transmission. To control spread, hospitals use contact precautions: placing patients in private rooms, using gowns and gloves, and dedicated equipment. Active surveillance testing identifies colonized patients early, enabling prompt isolation. Antibiotic stewardship minimizes unnecessary carbapenem use, reducing the selection of resistant strains.

A deeper explanation

The spread of CRE in healthcare facilities is driven by two linked mechanisms: the selective pressure of antibiotics and the mobility of resistance genes. Carbapenem use kills susceptible bacteria, giving resistant ones a competitive advantage. The resistant bacteria multiply, leading to colonization and potential infection. Patients can transmit bacteria to each other via healthcare workers' hands or shared equipment, a classic chain of transmission. Once established, CRE can become endemic, as control is harder when the bacteria are present in many patients asymptomatically. Effective control therefore requires breaking the transmission chain: early detection (surveillance cultures), isolation (contact precautions), and careful hand hygiene (alcohol-based rubs are less effective against CRE, so soap and water is often required). Antibiotic stewardship reduces the selective pressure, and sometimes, for outbreak control, decolonization protocols are used, though evidence is limited. Ultimately, preventing CRE spread is a multimodal effort that combines infection prevention and prudent antibiotic use, as the resistance genes can persist and spread even in the absence of active infection.

Keep FACTREE close

Internet access is required. Updates arrive when you reopen or reload the app. You may need to sign in again in the installed app.